Paul R. Fonteyne, Director at Apellis Pharmaceuticals, Inc. (APLS), bought 5,000 shares at $31.81 ($159K) on 2020-05-08, disclosed to the SEC on 2020-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |